{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:13:09Z","timestamp":1753891989504,"version":"3.41.2"},"reference-count":8,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2024.1504261","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T04:52:02Z","timestamp":1728881522000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: New players on the monoaminergic field: relevance to the mental disorders"],"prefix":"10.3389","volume":"15","author":[{"given":"Eliyahu","family":"Dremencov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Jezova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"B1","first-page":"12","article-title":"Pharmacology of rapid-onset antidepressant treatment strategies","volume":"62","author":"Blier","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s43440-022-00366-z","article-title":"Exposure to chronic stressor upsurges the excitability of serotoninergic neurons and diminishes concentrations of circulating corticosteroids in rats two weeks thereafter","volume":"74","author":"Dremencov","year":"2022","journal-title":"Pharmacol. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s43440-023-00485-1","article-title":"Effects of chronic delta-opioid receptor agonist on the excitability of hippocampal glutamate and brainstem monoamine neurons, anxiety, locomotion, and habituation in rats","volume":"75","author":"Dremencov","year":"2023","journal-title":"Pharmacol. Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.4149\/gpb_2017039","article-title":"Purinergic regulation of brain catecholamine neurotransmission: in vivo electrophysiology and microdialysis study in rats","volume":"36","author":"Dremencov","year":"2017","journal-title":"General Physiology Biophysics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/j.1755-5949.2010.00146.x","article-title":"Relevance of norepinephrine\u2013dopamine interactions in the treatment of major depressive disorder","volume":"16","author":"El Mansari","year":"2010","journal-title":"CNS Neurosci. and Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s12031-015-0536-3","article-title":"Interaction between brain histamine and serotonin, norepinephrine, and dopamine systems: in vivo microdialysis and electrophysiology study","volume":"56","author":"Flik","year":"2015","journal-title":"J. Mol. Neurosci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"108580","DOI":"10.1016\/j.pharmthera.2023.108580","article-title":"TAAR1 as an emerging target for the treatment of psychiatric disorders","volume":"253","author":"Liu","year":"2024","journal-title":"Pharmacol. Ther."},{"volume-title":"Stahl\u2019s essential psychopharmacology: prescriber\u2019s guide","year":"2024","author":"Stahl","key":"B8"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1504261\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T04:52:03Z","timestamp":1728881523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1504261\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":8,"alternative-id":["10.3389\/fphar.2024.1504261"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1504261","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"article-number":"1504261"}}